UNITED STATES
SECURITIES AND EXCHANGE COMMISSION

 

Washington, D.C. 20549

  

FORM 8-K

  

CURRENT REPORT

 

PURSUANT TO SECTION 13 OR 15(d) OF

 

THE SECURITIES EXCHANGE ACT OF 1934

 

Date of Report (Date of earliest event reported): October 9, 2015

  

Proto Labs, Inc.

 

(Exact name of registrant as specified in its charter)

  

Minnesota

 

001-35435

 

41-1939628

(State or other jurisdiction of incorporation)

  

(Commission File Number)

  

(IRS Employer Identification Number)

 

 

 

5540 Pioneer Creek Drive

 Maple Plain, Minnesota

 

55359

(Address of principal executive offices)

  

(Zip Code)

   

 

Registrant’s telephone number, including area code:

  

(763) 479-3680

  

Not Applicable

(Former name or former address, if changed since last report)

  

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

 

⃞ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

⃞ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

⃞ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

⃞ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

  

 

 
 
 

  

Item 7.01.     Regulation FD Disclosure.

 

On October 9, 2015, Proto Labs, Inc. (the “Company”) issued a press release announcing it closed on its acquisition of select assets and operations of Alphaform AG. This press release is furnished as Exhibit 99.1 hereto pursuant to Item 7.01 of this Current Report on Form 8-K, and shall not be deemed to be “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject to the liabilities under Section 18 of the Exchange Act. Furthermore, the information contained in Exhibit 99.1 shall not be deemed to be incorporated by reference into the filings of the Company under the Securities Act of 1933, as amended, or the Exchange Act.

  

Item 9.01.     Financial Statements and Exhibits.

 

(d) Exhibits

 

99.1

Press release of Proto Labs, Inc. dated October 9, 2015, announcing its acquisition of select assets and operations of Alphaform AG.

  

 

 
 
 

  

SIGNATURE

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

 

   

Proto Labs, Inc.

  
       
       

 

Date:

October 9, 2015

By:

/s/ Victoria M. Holt

  
     

Victoria M. Holt

  
     

President and Chief Executive Officer

  

 

 

 
 
 

 

EXHIBIT INDEX

  

Exhibit

Number

 

Description

  

Manner of Filing

   

 

    

99.1

  

Press release of Proto Labs, Inc. dated October 9, 2015, announcing its acquisition of select assets and operations of Alphaform AG.

  

Filed electronically

 



Exhibit 99.1

 

 

FOR IMMEDIATE RELEASE

 

Contact:

Bill Dietrick
Proto Labs
763-479-7664

bill.dietrick@protolabs.com 

  

Proto Labs Closes on Purchase of Portions of German Manufacturer Alphaform AG

Proto Labs’ acquisition extends additive manufacturing reach in Europe

 

MAPLE PLAIN, MINN.—October 9, 2015—Rapid manufacturer Proto Labs, Inc. (NYSE: PRLB) announced today that it has closed on the purchase of select assets and operations of German-based manufacturer Alphaform AG, which significantly extends Proto Labs’ additive manufacturing (3D printing) capabilities across Europe.

 

Alphaform is a leading service bureau headquartered in Feldkirchen (Munich), Germany. The acquisition includes Alphaform divisions operating in Germany, Finland and the United Kingdom. This acquisition will significantly expand Proto Labs’ recently launched additive manufacturing capabilities in Europe by adding selective laser sintering, direct metal laser sintering and additional stereolithography capabilities. The acquisition also includes the injection molding service currently offered by Alphaform Claho, in Eschenlohe, Germany. MediMet Precision Casting and Implants Technology GmbH, a 100 percent subsidiary of Alphaform AG is not part of the transaction.

 

“We believe Alphaform will expand our share of the additive manufacturing market in Europe,” says Vicki Holt, Proto Labs CEO. “This opportunity is also an ideal complement to our existing business.”

 

Proto Labs’ existing European business includes injection molding, CNC machining and stereolithography services operating out of Telford, England. The purchase also gives Proto Labs a major presence in Germany, which is the largest single market for the company’s services in Europe.

 

About Proto Labs

Proto Labs is the world’s fastest digital manufacturing source for custom prototypes and low-volume production parts. The technology-enabled company uses advanced 3D printing, CNC machining and injection molding technologies to produce parts within days. The result is an unprecedented speed-to-market value for product designers and engineers worldwide. Visit protolabs.com for more information.

 

 

Proto Labs (NYSE:PRLB)
Gráfico Histórico do Ativo
De Jun 2024 até Jul 2024 Click aqui para mais gráficos Proto Labs.
Proto Labs (NYSE:PRLB)
Gráfico Histórico do Ativo
De Jul 2023 até Jul 2024 Click aqui para mais gráficos Proto Labs.